
10/07/2025
NEWS SECTION💥💥
MIT scientists have developed a groundbreaking, ultra-affordable DNA sensor capable of detecting cancer and HIV.
This disposable, 50-cent device uses the CRISPR Cas12 enzyme to identify disease markers in samples like saliva, urine, or nasal swabs, providing instant results through an electrical signal.
Crafted from gold leaf and DNA strands, this innovative sensor operates without refrigeration and remains stable for up to two months, even in warm environments. This makes it ideal for widespread use, especially in regions with limited access to advanced medical facilities.
The research team is now moving towards field tests, aiming to make affordable, at-home diagnostics for critical diseases accessible globally. This advancement promises to transform personal healthcare by bringing rapid, reliable testing directly to your home.
How do you envision this technology impacting global health accessibility?